Back to Search Start Over

1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study.

Authors :
Merle, P.
Lim, H.Y.
Finn, R.S.
Ikeda, M.
Kudo, M.
Frenette, C.
Masi, G.
Kim, Y.J.
Gerolami, R.
Kurosaki, M.
Numata, K.
Klümpen, H-J.
Zebger-Gong, H.
Fiala-Buskies, S.
Ozgurdal, K.
Qin, S.
Source :
Annals of Oncology. 2020 Supplement 4, Vol. 31, pS699-S700. 2p.
Publication Year :
2020

Subjects

Subjects :
*HEPATOCELLULAR carcinoma
*REGORAFENIB
*SCIENTIFIC observation

Details

Language :
English
ISSN :
09237534
Volume :
31
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
152695661
Full Text :
https://doi.org/10.1016/j.annonc.2020.08.1126
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details